Cargando…
Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions
PURPOSE: Fluorescence guidance in surgical oncology provides the potential to realize enhanced molecular tumor contrast with dedicated targeted tracers, potentially with a microdose injection level. For most glioma tumors, the blood brain barrier is compromised allowing some exogenous drug/molecule...
Autores principales: | de Souza, Ana Luiza Ribeiro, Marra, Kayla, Gunn, Jason, Samkoe, Kimberley S., Hoopes, P. Jack, Feldwisch, Joachim, Paulsen, Keith D., Pogue, Brian W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209393/ https://www.ncbi.nlm.nih.gov/pubmed/27379987 http://dx.doi.org/10.1007/s11307-016-0980-7 |
Ejemplares similares
-
Fluorescent Affibody Peptide Penetration in Glioma Margin Is Superior to Full Antibody
por: Sexton, Kristian, et al.
Publicado: (2013) -
Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision: Literature Review and Novel Developments Toward Indirect Visualization
por: Samkoe, Kimberley S., et al.
Publicado: (2018) -
Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols
por: Wang, Cheng, et al.
Publicado: (2021) -
Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer
por: de Souza, Ana Luiza Ribeiro, et al.
Publicado: (2016) -
Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens
por: Chen, Yao, et al.
Publicado: (2023)